Current Management of Refractory Germ Cell Tumors and Future Directions-Reference-Cited by-同舟云学术

Current Management of Refractory Germ Cell Tumors and Future Directions

Published:2017-02 Issue:2 Volume:19 Page:
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Allen J. Clayton,Kirschner Austin,Scarpato Kristen R.,Morgans Alicia K.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-017-0572-y.pdf

Reference64 articles.

1. Hanna N, Einhorn LH. Testicular cancer: a reflection on 50 years of discovery. J Clin Oncol. 2014;32(28):3085–92.

2. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med. 1997;337(4):242–53.

3. Einhorn EH. Testicular cancer: an oncological success story. Clin Cancer Res. 1997;3(12 Pt 2):2630–2.

4. Loehrer Sr PJ, et al. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol. 1998;16(7):2500–4.

5. Motzer RJ, et al. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience. Semin Oncol. 1992;19(6 Suppl 12):8–11.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients;International Journal of Molecular Sciences;2023-04-26

2. A stroll through the present and future of testicular germ cell tumour biomarkers;Expert Review of Molecular Diagnostics;2023-04-25

3. Overcoming Chemotherapy Resistance in Germ Cell Tumors;Biomedicines;2022-04-22

4. Genomic Profile in a Non-Seminoma Testicular Germ-Cell Tumor Cohort Reveals a Potential Biomarker of Sensitivity to Platinum-Based Therapy;Cancers;2022-04-20

5. Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care;Frontiers in Cell and Developmental Biology;2022-04-08